Copy number variations (CNVs) contribute to genome variability and their pathogenic role is becoming evident in an increasing number of human disorders. Commercial assays for routine diagnosis of CNVs are available only for a fraction of known genomic rearrangements. Thus, it is important to develop flexible and cost-effective methods that can be adapted to the detection of CNVs of interest, both in research and clinical settings.
Methods
We describe a new multiplex PCR-based method for CNV analysis that exploits automated microfluidic capillary electrophoresis through lab-on-a-chip technology (LOC-CNV). We tested the reproducibility of the method and compared the results obtained by LOC-CNV with those obtained using previously validated semiquantitative assays such as multiplex ligation-dependent probe amplification (MLPA) and nonfluorescent multiplex PCR coupled to HPLC (NFMP-HPLC).
Results
The results obtained by LOC-CNV in control individuals and carriers of pathogenic MLH1 or BRCA1 genomic rearrangements (losses or gains) were concordant with those obtained by previously validated methods, indicating that LOC-CNV is a reliable method for the detection of genomic rearrangements.
Conclusion
Because of its advantages with respect to time, costs, easy adaptation of previously developed multiplex assays and flexibility in novel assay design, LOC-CNV may represent a practical option to evaluate relative copy number changes in genomic targets of interest, including those identified in genome-wide analyses.
IafrateA.J., FeukL., RiveraM.N., ListewnikM.L., DonahoeP.K., QiY., SchererS.W., LeeC.: Detection of large-scale variation in the human genome.Nat Genet, 36: 949–951, 2004.
FanciulliM., NorsworthyP.J., PetrettoE., DongR., HarperL., KameshL., HewardJ.M., GoughS.C., de SmithA., BlakemoreA.I., FroguelP., OwenC.J., PearceS.H., TeixeiraL., GuillevinL., GrahamD.S., PuseyC.D., CookH.T., VyseT.J., AitmanT.J.: FC-GR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity.Nat Genet, 39: 721–723, 2007.
9.
YangY., ChungE.K., WuY.L., SavelliS.L., NagarajaH.N., ZhouB., HebertM., JonesK.N., ShuY., KitzmillerK., BlanchongC.A., McBrideK.L., HigginsG.C., RennebohmR.M., RiceR.R., HackshawK.V., RoubeyR.A., GrossmanJ.M., TsaoB.P., BirminghamD.J., RovinB.H., HebertL.A., YuC.Y.: Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.Am J Hum Genet, 80: 1037–1054, 2007.
StensonP.D., MortM., BallE.V., HowellsK., PhillipsA.D., ThomasN.S., CooperD.N.: The Human Gene Mutation Database: 2008 update.Genome Med, 1: 13, 2009.
12.
Pritchard KI, Shepherd LE, O'Malley FP, Andrulis IL, Tu D, Bramwell VH, Levine MN; National Cancer Institute of Canada Clinical Trials Group: HER2 and responsiveness of breast cancer to adjuvant chemotherapy.N Engl J Med, 354: 2103–2111, 2006.
13.
HudisC.A.: Trastuzumab-mechanism of action and use in clinical practice.N Engl J Med, 357: 39–51, 2007.
14.
CarterN.P.: Methods and strategies for analyzing copy number variation using DNA microarrays.Nat Genet, 39: S16–S21, 2007.
15.
LeeC., IafrateA.J., BrothmanA.R.: Copy number variations and clinical cytogenetic diagnosis of constitutional disorders.Nat Genet, 39: S48–S54, 2007.
16.
LiuZ., ObenaufA.C., SpeicherM.R., KopanR.: Rapid identification of homologous recombinants and determination of gene copy number with reference/query pyrosequencing (RQPS).Genome Res, 19: 2081–2089, 2009.
17.
ArmourJ.A., PallaR., ZeeuwenP.L., den HeijerM., SchalkwijkJ., HolloxE.J.: Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats.Nucleic Acids Res, 35: e19, 2007.
18.
DehainaultC., LaugéA., Caux-MoncoutierV., Pagès-BerhouetS., DozF., DesjardinsL., CouturierJ., Gauthier-VillarsM., Stoppa-LyonnetD., HoudayerC.: Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene.Nucleic Acids Res, 32: e139, 2004.
19.
Eijk-Van OsP.G., SchoutenJ.P.: Multiplex ligation-dependent probe amplification (MLPA®) for the detection of copy number variation in genomic sequences.Methods Mol Biol, 688: 97–126, 2011.
20.
CharbonnierF., OlschwangS., WangQ., BoissonC., MartinC., BuisineM.P., PuisieuxA., FrebourgT.: MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.Cancer Res, 62: 848–853, 2002.
21.
De LellisL., CuriaM.C., CatalanoT., De ToffolS., BassiC., MareniC., BertarioL., BattistaP., Mariani-CostantiniR., RadiceP., CamaA.: Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements.Hum Mutat, 27: 1047–1056, 2006.
22.
WalkerS., JanyakhantikulS., ArmourJ.A.: Multiplex paralogue ratio tests for accurate measurement of multiallelic CNVs.Genomics, 93: 98–103, 2009.
23.
WehnerM., MangoldE., SengtellerM., FriedrichsN., AretzS., FriedlW., ProppingP., PagenstecherC.: Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.Eur J Hum Genet, 13: 983–986, 2005.
24.
CasilliF., Di RoccoZ.C., GadS., TournierI., Stoppa-LyonnetD., FrebourgT., TosiM.: Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.Hum Mutat, 20: 218–226, 2002.
25.
den DunnenJ.T., AntonarakisS.E.: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.Hum Mutat, 15: 7–12, 2000.
26.
VeschiS., AcetoG., SciolettiA.P., GattaV., PalkaG., CamaA., Mariani-CostantiniR., BattistaP., CalòV., BarberaF., BazanV., RussoA., StuppiaL.: High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability.Ann Oncol, 6: vi86–92, 2007.
27.
AtenE., WhiteS.J., KalfM.E., VossenR.H., ThygesenH.H., RuivenkampC.A., KriekM., BreuningM.H., den DunnenJ.T.: Methods to detect CNVs in the human genome.Cytogenet Genome Res, 123: 313–321, 2008.
28.
HeathK.E., DayI.N., HumphriesS.E.: Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene.J Med Genet, 37: 272–280, 2000.
29.
NakagawaH., HampelH., de la ChapelleA.: Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques.Hum Mutat, 22: 258, 2003.
30.
CoelhoA., PicançoI., SeuanesF., SeixasM.T., FaustinoP.: Novel large deletions in the human alpha-globin gene cluster: clarifying the HS-40 long-range regulatory role in the native chromosome environment.Blood Cells Mol Dis, 45: 147–153, 2010.
31.
KillianA., Di FioreF., Le PessotF., BlanchardF., LamyA., RauxG., FlamanJ.M., PaillotB., MichelP., SabourinJ.C., TuechJ.J., MichotF., KerckaertJ.P., SesboüéR., FrebourgT.: A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer.Gastroenterology, 132: 645–653, 2007.
32.
CastellsaguéE., GonzálezS., NadalM., CamposO., GuinóE., UriosteM., BlancoI., FrebourgT., CapelláG.: Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments.Clin Chem, 54: 1132–1140, 2008.
